Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Boyer

Showing results (331-340 of 428) with videos related to

Pageof 43
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 14, 2000
A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisonsB Hanau-Berçot, I Grémy, L Raskine, et al.
JAMA Ophthalmology|March 18, 2021
Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical TrialJeffrey S Heier, David M Brown, Sumit P Shah, et al.
Translational Vision Science & Technology|December 19, 2024
Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular EdemaDavid S Boyer, Nathan C Steinle, Joel A Pearlman, et al.
The Journal of Rheumatology|December 1, 1994
Prevalence of spondyloarthropathies in Alaskan EskimosG S Boyer, D W Templin, J C Cornoni-Huntley, et al.
The Journal of Rheumatology|February 11, 1998
Prevalence of rheumatoid arthritis in circumpolar native populationsG S Boyer, L I Benevolenskaya, D W Templin, et al.
Retina (Philadelphia, Pa.)|March 6, 2020
PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATIONBaruch D Kuppermann, Sunil S Patel, David S Boyer, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 15, 2006
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS StudyJeffrey S Heier, David S Boyer, Thomas A Ciulla, et al.
Ophthalmology|December 3, 2014
Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2Peter A Campochiaro, Raafay Sophie, Michael Tolentino, et al.
American Journal of Ophthalmology|December 11, 2012
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS studyDavid M Brown, Jeffrey S Heier, W Lloyd Clark, et al.
Plant Physiology|April 1, 1996
Genetically Engineered Plants Resistant to Soil Drying and Salt Stress: How to Interpret Osmotic Relations?A. Blum, R. Munns, J. B. Passioura, et al.
Pageof 43

Showing results (331-340 of 428) with videos related to

Sort By:
Pageof 43
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 14, 2000
A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisonsB Hanau-Berçot, I Grémy, L Raskine, et al.
JAMA Ophthalmology|March 18, 2021
Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical TrialJeffrey S Heier, David M Brown, Sumit P Shah, et al.
Translational Vision Science & Technology|December 19, 2024
Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular EdemaDavid S Boyer, Nathan C Steinle, Joel A Pearlman, et al.
The Journal of Rheumatology|December 1, 1994
Prevalence of spondyloarthropathies in Alaskan EskimosG S Boyer, D W Templin, J C Cornoni-Huntley, et al.
The Journal of Rheumatology|February 11, 1998
Prevalence of rheumatoid arthritis in circumpolar native populationsG S Boyer, L I Benevolenskaya, D W Templin, et al.
Retina (Philadelphia, Pa.)|March 6, 2020
PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATIONBaruch D Kuppermann, Sunil S Patel, David S Boyer, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 15, 2006
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS StudyJeffrey S Heier, David S Boyer, Thomas A Ciulla, et al.
Ophthalmology|December 3, 2014
Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2Peter A Campochiaro, Raafay Sophie, Michael Tolentino, et al.
American Journal of Ophthalmology|December 11, 2012
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS studyDavid M Brown, Jeffrey S Heier, W Lloyd Clark, et al.
Plant Physiology|April 1, 1996
Genetically Engineered Plants Resistant to Soil Drying and Salt Stress: How to Interpret Osmotic Relations?A. Blum, R. Munns, J. B. Passioura, et al.
Pageof 43